These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
456 related items for PubMed ID: 16298835
1. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS). Ross J, Teesson M, Darke S, Lynskey M, Ali R, Ritter A, Cooke R. Drug Alcohol Rev; 2005 Sep; 24(5):411-8. PubMed ID: 16298835 [Abstract] [Full Text] [Related]
2. Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence. Darke S, Hetherington K, Ross J, Lynskey M, Teesson M. Drug Alcohol Rev; 2004 Jun; 23(2):177-83. PubMed ID: 15370024 [Abstract] [Full Text] [Related]
3. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Teesson M, Ross J, Darke S, Lynskey M, Ali R, Ritter A, Cooke R. Drug Alcohol Depend; 2006 Jun 28; 83(2):174-80. PubMed ID: 16343809 [Abstract] [Full Text] [Related]
4. Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and risk factors. Darke S, Ross J, Lynskey M, Teesson M. Drug Alcohol Depend; 2004 Jan 07; 73(1):1-10. PubMed ID: 14687954 [Abstract] [Full Text] [Related]
5. Post-traumatic stress disorder among people with heroin dependence in the Australian treatment outcome study (ATOS): prevalence and correlates. Mills KL, Lynskey M, Teesson M, Ross J, Darke S. Drug Alcohol Depend; 2005 Mar 07; 77(3):243-9. PubMed ID: 15734224 [Abstract] [Full Text] [Related]
9. Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking. Teesson M, Havard A, Fairbairn S, Ross J, Lynskey M, Darke S. Drug Alcohol Depend; 2005 Jun 01; 78(3):309-15. PubMed ID: 15893162 [Abstract] [Full Text] [Related]
10. Depression among heroin users: 12-Month outcomes from the Australian Treatment Outcome Study (ATOS). Havard A, Teesson M, Darke S, Ross J. J Subst Abuse Treat; 2006 Jun 01; 30(4):355-62. PubMed ID: 16716851 [Abstract] [Full Text] [Related]
11. Non-fatal heroin overdose, treatment exposure and client characteristics: findings from the Australian treatment outcome study (ATOS). Darke S, Williamson A, Ross J, Teesson M. Drug Alcohol Rev; 2005 Sep 01; 24(5):425-32. PubMed ID: 16298837 [Abstract] [Full Text] [Related]
12. The Australian Treatment Outcome Study (ATOS): what have we learnt about treatment for heroin dependence? Darke S, Ross J, Teesson M. Drug Alcohol Rev; 2007 Jan 01; 26(1):49-54. PubMed ID: 17364836 [Abstract] [Full Text] [Related]
13. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation. Ngo HT, Tait RJ, Hulse GK. Arch Gen Psychiatry; 2008 Apr 01; 65(4):457-65. PubMed ID: 18391134 [Abstract] [Full Text] [Related]
15. Changes and predictors of change in the physical health status of heroin users over 24 months. Williamson A, Darke S, Ross J, Teesson M. Addiction; 2009 Mar 01; 104(3):465-70. PubMed ID: 19207357 [Abstract] [Full Text] [Related]